Home/Filings/4/0001127602-25-003153
4//SEC Filing

Torres John D 4

Accession 0001127602-25-003153

CIK 0001069202other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 3:49 PM ET

Size

18.2 KB

Accession

0001127602-25-003153

Insider Transaction Report

Form 4
Period: 2025-02-04
Torres John D
EVP, Chief Legal Officer
Transactions
  • Exercise/Conversion

    Common Stock, Par Value $0.01 Per Share

    2025-02-04$259.56/sh+1,103$286,2956,392 total
  • Disposition to Issuer

    Common Stock, Par Value $0.01 Per Share

    2025-02-04$582.41/sh695$404,7755,697 total
  • Sale

    Common Stock, Par Value $0.01 Per Share

    2025-02-04$582.59/sh715$416,5524,341 total
  • Sale

    Common Stock, Par Value $0.01 Per Share

    2025-02-04$584.06/sh285$166,4574,056 total
  • Exercise/Conversion

    Non-qualified Stock Appreciation Right

    2025-02-041,0200 total
    Exercise: $328.65From: 2022-12-10Exp: 2028-12-10Common Stock, Par Value $0.01 Per Share (1,020 underlying)
  • Exercise/Conversion

    Common Stock, Par Value $0.01 Per Share

    2025-02-04$328.65/sh+1,020$335,2235,289 total
  • Disposition to Issuer

    Common Stock, Par Value $0.01 Per Share

    2025-02-04$582.41/sh641$373,3255,056 total
  • Sale

    Common Stock, Par Value $0.01 Per Share

    2025-02-04$581.96/sh787$458,0033,269 total
  • Exercise/Conversion

    Non-qualified Stock Appreciation Right

    2025-02-041,1031,104 total
    Exercise: $259.56From: 2023-12-09Exp: 2029-12-09Common Stock, Par Value $0.01 Per Share (1,103 underlying)
Footnotes (3)
  • [F1]Reflects a weighted average sale price of $582.59 at prices ranging from $582.410 to $583.130 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F2]One third of the Stock Appreciation Rights became exercisable on 12/10/2022 and each year thereafter. The entire grant became fully exercisable on 12/10/2024.
  • [F3]One third of the Stock Appreciation Rights became exercisable on 12/09/2023 and each year thereafter. The entire grant will become fully exercisable on 12/09/2025.

Issuer

LENNOX INTERNATIONAL INC

CIK 0001069202

Entity typeother

Related Parties

1
  • filerCIK 0001296605

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 3:49 PM ET
Size
18.2 KB